Predicted 59kDa; Observed 100kDa Antibodies

Predicted 59kDa; Observed 100kDa

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK